Høiby N - Search Results

1

Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment.

Valerius NH, Koch C, Høiby N. Valerius NH, et al. Among authors: hoiby n. Lancet. 1991 Sep 21;338(8769):725-6. doi: 10.1016/0140-6736(91)91446-2. Lancet. 1991. PMID: 1679870 Clinical Trial.

2

Ciprofloxacin in sweat and antibiotic resistance. The Copenhagen Study Group on Antibiotics in Sweat.

Høiby N, Johansen HK. Høiby N, et al. Lancet. 1995 Nov 4;346(8984):1235. doi: 10.1016/s0140-6736(95)92946-0. Lancet. 1995. PMID: 7475694 No abstract available.

3

Pathogenesis of cystic fibrosis.

Koch C, Høiby N. Koch C, et al. Among authors: hoiby n. Lancet. 1993 Apr 24;341(8852):1065-9. doi: 10.1016/0140-6736(93)92422-p. Lancet. 1993. PMID: 7682274 Review. No abstract available.

4

Comparative immunochemistry of lipopolysaccharides from typable and polyagglutinable Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis.

Fomsgaard A, Conrad RS, Galanos C, Shand GH, Høiby N. Fomsgaard A, et al. Among authors: hoiby n. J Clin Microbiol. 1988 May;26(5):821-6. doi: 10.1128/jcm.26.5.821-826.1988. J Clin Microbiol. 1988. PMID: 3133386 Free PMC article.

5

Agglutinating antibody titers to members of the family Legionellaceae in cystic fibrosis patients as a result of cross-reacting antibodies to Pseudomonas aeruginosa.

Collins MT, McDonald J, Høiby N, Aalund O. Collins MT, et al. Among authors: hoiby n. J Clin Microbiol. 1984 Jun;19(6):757-62. doi: 10.1128/jcm.19.6.757-762.1984. J Clin Microbiol. 1984. PMID: 6206086 Free PMC article.

6

Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin.

Møller NE, Eriksen KR, Feddersen C, Flensborg EW, Høiby N, Norn S, Rosendal K, Schiøtz PO, Skov PS. Møller NE, et al. Among authors: hoiby n. Eur J Respir Dis. 1982 Mar;63(2):130-9. Eur J Respir Dis. 1982. PMID: 6461561

7

Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.

Møller NE, Høiby N. Møller NE, et al. Among authors: hoiby n. Scand J Infect Dis Suppl. 1981;29:87-91. Scand J Infect Dis Suppl. 1981. PMID: 6458884

8

Antimicrobial Activity of α-Peptide/β-Peptoid Lysine-Based Peptidomimetics Against Colistin-Resistant Pseudomonas aeruginosa Isolated From Cystic Fibrosis Patients.

Molchanova N, Wang H, Hansen PR, Høiby N, Nielsen HM, Franzyk H. Molchanova N, et al. Among authors: hoiby n. Front Microbiol. 2019 Feb 20;10:275. doi: 10.3389/fmicb.2019.00275. eCollection 2019. Front Microbiol. 2019. PMID: 30842761 Free PMC article.

9

P. aeruginosa flow-cell biofilms are enhanced by repeated phage treatments but can be eradicated by phage-ciprofloxacin combination.

Henriksen K, Rørbo N, Rybtke ML, Martinet MG, Tolker-Nielsen T, Høiby N, Middelboe M, Ciofu O. Henriksen K, et al. Among authors: hoiby n. Pathog Dis. 2019 Mar 1;77(2):ftz011. doi: 10.1093/femspd/ftz011. Pathog Dis. 2019. PMID: 30821815

10

Increased bactericidal activity of colistin on Pseudomonas aeruginosa biofilms in anaerobic conditions.

Kolpen M, Appeldorff CF, Brandt S, Mousavi N, Kragh KN, Aydogan S, Uppal HA, Bjarnsholt T, Ciofu O, Høiby N, Jensen PØ. Kolpen M, et al. Among authors: hoiby n. Pathog Dis. 2016 Feb;74(1):ftv086. doi: 10.1093/femspd/ftv086. Epub 2015 Oct 12. Pathog Dis. 2016. PMID: 26458402 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results